High Potency Active Pharmaceutical Ingredients; Effective at Much Smaller Dosage Levels than Traditional APIs

 

High Potency Active Pharmaceutical Ingredients

High potency active pharmaceutical ingredients (HPAPIs) are compounds that elicit a biological response at a very low dose/concentrations, such as a daily therapeutic dose of <10 mg or an occupational exposure limit (OEL) of < 10 μg/m3 at an eight-hour time-weighted average. High potent drugs represent a growing proportion of medicines, including therapies in development and those commercially available. The active ingredient in a pharmaceutical drug is called an API. An example of an API is the acetaminophen contained in a pain relief tablet.

The active ingredient in a biological drug is called a bulk process intermediate (BPI). Demand for High Potency Active Pharmaceutical Ingredients is increasing at a rapid pace due to its ability to target diseased cells more precisely and selectively than other APIs. A highly potent drug (bisoprolol, bumetanide, risperidone, alprazolam, and fentanyl) evokes a given response at low concentrations, whereas a drug of lower potency (metoprolol, furosemide, ziprasidone, diazepam, and meperidine) evokes the same response only at higher concentrations.

High potency active pharmaceutical ingredients are compounds that elicit a biological response at a very low dose. However, any type of compound can be highly potent if it causes a response at a low dose. A substance with high potency will have a big effect on the body, and something with low potency will have a smaller one. Many of these drugs have accelerated timelines for approval & commercial development. HPAPI services by Piramal Pharma offer manufacturing of HPAPIs through its FDA-approved cGMP state-of-the-art facility in the U.S.

Potency is an expression of a drug's activity in terms of the concentration or amount of a drug needed to produce the defined effect, while clinical efficacy judges a drug's therapeutic effectiveness in humans. High potency active pharmaceutical ingredients (HPAPI) represent an increasingly significant share of the pharmaceutical drug pipeline.

Comments

Popular posts from this blog

Liquid handling systems range from simple volumetric pipettes to robotic assisted liquid handling

Cervical cancer drugs are the earliest signs of cervical cancer.

Start-stop Battery are increasingly requested by automotive manufacturers to reduce CO2 emissions.